2020

Abstract blue cross shape with flowing dark teal wave lines on a solid black background.
Abstract soft light blue gradient glow on a solid white background.
04 • 29 • 2020
NervGen Pharma Reports 2019 Year End Results / Phase I Clinical Study Remains on Track for Q4 2020
04 • 06 • 2020
NervGen Pharma Provides a Corporate Update in Response to the COVID-19 Pandemic / Announces Upcoming Presentation at Solebury Trout Virtual Investor Conference on April 7th / Phase 1 Clinical Study Remains on Track for Q4 2020
02 • 26 • 2020
NervGen Pharma Provides a Development Update on its Lead Product NVG-291
02 • 24 • 2020
NervGen Pharma Appoints Bill Adams as Chief Financial Officer
01 • 13 • 2020
NervGen Pharma Responds To Recent Increase In Market Activity
1 2 3